Gesundheitsökonomie und Ressourcenallokation am Lebensende
Health economics and resource allocation at the end of life
Universität Heidelberg & Deutsches Krebsforschungszentrum, Abteilung für Gesundheitsökonomie Heidelberg Deutschland
Search for other papers by Michael Schlander in
Current site
Google Scholar
Abstract
Gesundheitsökonomische Evaluationen der medizinischen Versorgung am Lebensende, die qualitative Standards der Disziplin erfüllen, sind nach wie vor selten und weisen zwar auf Kosteneinsparungen hin, zeichnen aber hinsichtlich Kosteneffektivität kein einheitliches Bild. Im vorliegenden Beitrag wird argumentiert, dass die (quasi-)utilitaristische Logik, die konventionellen Kosten-Nutzen- und Kosteneffektivitäts-Analysen zugrunde liegt, zu Schlussfolgerungen führen kann, die weder mit vorherrschenden sozialen Normen und Präferenzen übereinstimmen noch aus ethischer Sicht überzeugen können.
Abstract
Health economic evaluations of medical care at the end of life, which fulfill established quality standards of the discipline, have remained scarce. While the literature points to potential cost savings, evidence on cost effectiveness is mixed. It will be argued that the underlying logic of conventional cost benefit and cost effectiveness analyses, which are inspired by utilitarian thought, may result in conclusions that are inconsistent with prevailing social norms and preferences, and may be less than convincing from an ethical perspective.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Ackerman, F., and Heinzerling, L. (2004). Priceless: On Knowing the Price of Everything and the Value of Nothing. New York: The New Press.
-
Bajwah, S., Oluyase, A. O., Yi, D., Gao, W., Evans, C. J., Grande, G., Todd, C., Costantini, M., Murtagh, F. E., and Higginson, I. J. (2020). The effectiveness and cost‐effectiveness of hospital‐based specialist palliative care for adults with advanced illness and their caregivers. Cochrane Evidence Review.
-
Baumol, W. J. (2012). The Cost Disease. Why Computers Get Cheaper and Health Care Doesn’t. New Haven: Yale University Press.
-
Baumol, W. J., and Bowen, W. G. (1965). On the Performing Arts: The Anatomy of Their Economic Problems. The American Economic Review 55, 495–502.
-
Black, W. C. (1990). The cost-effectiveness plane: a graphic representation of cost-effectiveness. Medical Decision Making 10, 212–215.
-
Blaug, M. (1980). The Methodology of Economics (Or how economists explain). Cambridge, UK: Cambridge University Press.
-
Boadway, R. W., and Bruce, N. (1984). Welfare Economics. Oxford: Basil Blackwell.
-
Bradley, N., Loyd Williams, M., and Dowrick, C. (2018). Effectiveness of palliative care interventions offering social support to people with life-limiting illness – A systematic review. European Journal of Cancer Care 27 (3), e12837.
-
Breyer, F., Zweifel, P., und Kifmann, M. (2012). Gesundheitsökonomik. Berlin, Heidelberg: Springer-Gabler.
-
Brockhaus – Die Enzyklopädie in 24 Bänden (20 1997): Effizienz. Leipzig, Mannheim.
-
Broome, J. (1978). Trying to value a life. Journal of Political Economics 9, 91–100.
-
Bundesministerium für Wirtschaft und Klimaschutz (2023). Gesundheitswirtschaft – Fakten & Zahlen, Daten 2022: Ergebnisse der Gesundheitswirtschaftlichen Gesam trechnung. Stand April 2023. Online unter: https://www.bmwk.de/Redaktion/DE/Publikationen/Wirtschaft/gesundheitswirtschaft-fakten-zahlen-2022.pdf?__blob=publicationFile&v=3 (Zugriff: 10.06.2024).
-
Culyer, A. J. (1989). The normative economics of health care finance and provision. Oxford Review of Economic Policy 5, 34–58.
-
Culyer, A. J. (1997). The rationing debate: Maximising the health of the whole community. The case for. British Medical Journal 314, 667–669.
-
Daniels, N., and Sabin, J. E. (2002). Setting limits fairly – can we learn to share medical resources? Oxford: Oxford University Press.
-
Drummond, M. F., Sculpher, M., Torrance, G. W., et al. (2005). Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
-
Dupuit, J. (1844). De la Mesure de l’Utilité des Travaux Publiqures. Annales des Ponts et Chaussees 2, 8. [Nachdruck (1952) in englischer Übersetzung: On the measurement of the utility of public works. International Economic Papers 2, 83–110.]
-
Feeny, D., and Torrance, G. W. (1989). Incorporating utility-based quality-of-life assessment in clinical trials: Two examples. Hamilton, Ontario (Kanada): Centre for Health Economics and Policy Analysis, McMaster University.
-
Felder, S., Meier, M., and Schmitt, H. (2000). Health care expenditure in the last months of life. Journal of Health Economics 19, 679–695.
-
Fischer, C., Masel, E. K., and Simon, J. (2024). Methodological factors regarding patient-reported outcome information for value assessment in palliative care. Annals of Palliative Medicine 13 (2), 440–444.
-
Friedman, M. (1992). Input and Output of Medical Care. Essays in Public Policy 28, 1–16.
-
Fuchs, V. R. (1972). Health care and the Unites States economic system. An essay in abnormal physiology. Milbank Memorial Fund Quarterly 50 (2), 211–244.
-
Gallet, C. A., and Doucouliagos, H. (2017). The impact of healthcare spending on health outcomes: a meta-regression analysis. Social Science & Medicine 179, 9–17.
-
Gans, O., und Marggraf, R. (1997). Kosten-Nutzen-Analyse und ökonomische Politikbewertung 1: Wohlfahrtsmessung und betriebswirtschaftliche Investitionskriterien. Berlin, Heidelberg, New York: Springer.
-
Gerlinger, T. (2006). Direkte Kostenbeteiligung in der Gesetzlichen Krankenversicherung – Ein sinnvolles Instrument? WSI Mitteilungen 4/2006, 227–230.
-
Gold, M. R., Siegel, J. E., Russell, L. B., and Weinstein, M. C. (1996). Cost-Effectiveness in Health and Medicine. New York, Oxford: Oxford University Press.
-
Gomes, B., Calanzani, N., Curiale, V., McCrone, P., Higginson, I. J., and de Brito, M. (2013). Effectiveness and cost-effectiveness of home-based palliative care services for adults with advanced illness and their caregivers. Cochrane Evidence Synthesis.
-
Gonzalez-Jaramillo, V., Fuhrer, V., Gonzalez-Jaramillo. N., Kopp-Heim, D., Eychmüller, S., and Maessen, M. (2021). Palliative & Supportive Care 19 (4), 474–487.
-
Haun, M. W., Estel, S., Rücker, G., Friederich, H., Villalobos, M., Thomas, M., and Hartmann, M. (2017). Early palliative care for adults with advanced cancer. Cochrane Evidence Review.
-
Hicks, J. R. (1939). The Foundations of Welfare Economics. Economic Journal 49, 696–712.
-
Hicks, S., Davidson, M., Efstathiou, N., and Guo, P. (2022). Effectiveness and cost effectiveness of palliative care interventions in people with chronic heart failure and their caregivers: a systematic review. BMC Palliative Care 21, 205.
-
Hume, D. (1739). A Treatise of Human Nature. London: John Noon.
-
Husereau, D., Drummond, M., Augustovski, F., de Bekker.-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., Mauskopf, J., Mullins, C. D., Petrou, S., Pwu, R.-F., Staniszewska, S.; CHEERS 2022 ISPOR Good research Practices Task Force (2022). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. Health Policy Open 3, 1000063.
-
Johannesson, M., Pliskin, J. S., and Weinstein, M. C. (1994). A note on QALY s, time trade-off and discounting. Medical Decision-Making 14, 142–149.
-
Johnston, B. M., McCauley, R., McQuillan, R., Tabbitte, M., Honohan, C., Mockler, D., Thomas, S., and May, P. (2020). Effectiveness and cost-effectiveness of out-of-hours palliative care: a systematic review. HRB Open Research 3, 9.
-
Kaldor, N. (1939). Welfare propositions of economists and interpersonal comparison of utility. Economic Journal 49, 549–552.
-
Klare, J. (2011). Was bin ich wert? Eine Preisermittlung. Berlin: Suhrkamp.
-
Leget, C. (2021). Der innere Raum. Wie wir erfüllt leben und gut sterben können. Ostfildern: Patmos-Verlag.
-
Leidl, R. (2003). Der Effizienz auf der Spur: Eine Einführung in die ökonomische Evaluation. In: F. W. Schwartz, B. Badura, R. Busse et al., Hrsg., Das Public Health Buch: Gesundheit und Gesundheitswesen. 2. Aufl. München, Jena: Urban & Fischer, 461–484.
-
Lubitz, J. D., and Riley, G. F. (1993). Trends in Medicare payments in the last year of life. New England Journal of Medicine 328, 1092–1096.
-
Lübbe, W. (2004). Lebensnotstand – Ende der Normativität? Untersuchung einer Grauzone im Unrecht des Tötens. In: W. Lübbe, Hrsg., Tödliche Entscheidung. Allokation von Leben und Tod in Zwangslagen. Paderborn: Mentis-Verlag.
-
Lübbe, W. (2015). Nonaggregationismus. Grundlagen der Allokationsethik. Münster: Mentis-Verlag.
-
Newhouse, J. P. (1992). Medical Care Costs: How Much Welfare Loss? Journal of Economic Perspectives 6 (3), 3–21.
-
Newhouse, J. P. (1993). Free for All? Lessons from the RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press.
-
Noll, P. (1984). Diktate über Sterben und Tod. Mit Totenrede von Max Frisch. Zürich: pendo-Verlag.
-
Nord, E. (1999). Cost-value analysis in health care: making sense out of QALY s. Cambridge: Cambridge University Press.
-
Nord, E., Richardson, J., Street, A., Kuhse, H., and Singer, P. (1995). Maximizing health benefits versus egalitarianism: an Australian survey of health issues. Social Science & Medicine 41, 1429–1437.
-
OECD (2023). Health at a Glance 2023 – OECD Indicators. Paris: OECD Publishing. Online unter: https://doi.org/10.1787/7a7afb35-en (Zugriff: 17.06.2024).
-
Pauly, M. V. (2003). Foreword. In: P. J. Hammer, D. Haas-Wilson, M. A. Peterson and W. M. Sage, Eds., Uncertain Times: Kenneth Arrow and the Changing Economics of Health Care. Durham, London: Duke University Press, vii–xii.
-
Plaul, C. (2017). Die Palliativversorgung in Deutschland im Spiegel der Gesundheitsökonomie. Dissertation, Technische Universität Dresden.
-
Radu, P., Kumar, G., Cubi-Molla, P., Garau, M., Bell, E., Pan, J., Gilardino, R., Van Bavel, J., Brandtmüller, A., Nelson, K., and Goodall, M. (2024). Navigating change: a comparative analysis across health technology assessment agencies on their positions on five key topics. London: Office of Health Economics.
-
Rakowski, E. (1991). Equal Justice. Oxford: Oxford University Press.
-
Rawls, J. (1971). A Theory of Justice. Oxford: Oxford University Press.
-
Richardson, J., and McKie, J. (2005). Empiricism, ethics and orthodox economic theory: what is the appropriate basis for decision-making in the health sector? Social Science & Medicine 60, 265–275.
-
Richardson, J., and McKie, J. (2007). Economic evaluation of services for a National Health Scheme: the case for a fairness-based framework. Journal of Health Economics 26 (4), 785–799.
-
Richardson, J., and Schlander, M. (2018). Health technology assessment (HTA) and economic evaluation: efficiency or fairness first. Journal of Market Access & Health Policy 7, 1557981.
-
Riley, G. F., and Lubitz, J. D. (2010). Long-Term Trends in Medicare Payments in the Last Year of Life. Health Services Research 45 (2), 565–576.
-
Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen (1996). Gesundheitswesen in Deutschland. Kostenfaktor und Zukunftsbranche. Baden-Baden: Nomos.
-
Schlander, M. (2005). Kosteneffektivität und Ressourcenallokation: Gibt es einen normativen Anspruch der Gesundheitsökonomie? In: H. A. Kick und J. Taupitz, Hrsg., Gesundheitswesen zwischen Wirtschaftlichkeit und Menschlichkeit, Münster: LIT-Verlag, 37–112.
-
Schlander, M. (2009). Gesundheitsökonomie: Der Effizienz auf der Spur. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 103, 117–125.
-
Schlander, M. (2010). Measures of efficiency in healthcare: QALM s about QALY s? Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 104, 214–226.
-
Schlander, M., Thielscher, C., and Schwarz, O. (2004). Affordability Sensitive To Economic Growth Rates. Health Affairs 23 (1), 276–277.
-
Schlander, M., Thielscher, C., und Schwarz, O. (2005). Gesundheitsausgaben in Deutschland: Eine makroökonomische Analyse ihrer langfristigen Finanzierbarkeit. In: B. Kremin-Buch, F. Unger, H. Walz und E. Häusler, Hrsg., Gesundheitsökonomie – Eine Langfristorientierung. Sternenfels: Verlag Wissenschaft & Praxis.
-
Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P., Nord, E., Persson, U., Postma, M., Richardson, J., Simoens, S., de Solà-Morales, O., Tolley, K., and Toumi, M. (2014). Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. Journal of Comparative Effectiveness Research 3 (4), 399–422.
-
Schlander, M., Hernandez-Villafuerte, K., und Thielscher, C. (2018). Kosten der Onkologie in Deutschland. Forum 33, 330–337.
-
Schlander M., van Harten, W., Retèl, V. P., Pham, P. D., Vancoppenolle, J. M., Ubels, J., Seoane López, O., Quirland, C., Maza, F., Aas, E., Crusius, B., Escobedo, A., Franzen, N., Fuentes-Cid, J., Hernandez, D., Hernandez-Villafuerte, K., Kirac, I., Paty, A., Philip, T., Smeland, S., Sullivan, R., Vanni, E., Varga, S., Vermeulin, T. and Eckford, R. D. (2024). The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions. The Lancet Oncology 25, e152–e163.
-
Sen, A. (2002). Why health equity? Health Economics 11 (8), 659–666.
-
Sozialgesetzbuch V. Fünftes Buch, Gesetzliche Krankenversicherung. §12, Wirtschaft- lichkeitsgebot.
-
Smith, S., Brick, A., O’Hara, S., and Normand, C. (2014). Evidence on cost and cost-effectiveness of palliative care: a literature review. Palliative Medicine 28 (2), 130–150.
-
Statistisches Bundesamt (2024). Gesundheitsausgabenrechnung (Code 23611). Online unter: https://www-genesis.destatis.de/genesis/online?sequenz=statistikTabellen&selectionname=23611#abreadcrumb (Zugriff: 10.06.2024).
-
Vanberg, V. (2018). Individual choice and social welfare: Theoretical foundations of political economy. Freiburger Diskussionspapiere zur Ordnungsökonomik, Np. 10/13.
-
Weinstein, M. C., and Manning, W. G. (1997). Theoretical issues in cost-effectiveness analysis. Journal of Health Economics 16, 121–128.
-
Weinstein, M. C., and Stason, W. B. (1977). Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296, 716–721.
-
Wichmann, A. B., Adang, E. M. M., Stalmeier, P. F. M., Kristanti, S., van den Block, L., Vernooij-Dassen, M. J. F. J., Engels, Y., on behalf of PACE (2017). The use of Quality-Adjusted Life Years in cost-effectiveness analyses in palliative care: Mapping the debate through an integrative review. Palliative Medicine 31 (4), 306–322.
-
Williams, A. H. (1985). Economics of coronary artery bypass grafting. British Medical Journal (Clinical Research Edition) 291, 326–329.
-
Zweifel, P., Felder, S., und Meier, M. (1996). Demographische Alterung und Gesundheitskosten: Eine Fehlinterpretation. In: P. Oberender, Hrsg., Alter und Gesundheit. Gesundheitsökonomische Beiträge, Band 26. Baden-Baden: Nomos 1996, 29–46.
-
Zweifel, P., Felder, S., and Meier, M. (1999). Ageing of population and health expenditure: a red herring? Health Economics 8, 485–496.
-
Zweifel, P., Felder, S., and Werblow, A. (2004). Population ageing and health care expenditure: new evidence on the „red herring“. Geneva Papers on Risk and Insurance: Issues and Practice 29 (4), 653–667.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 8 | 8 | 8 |
| Full Text Views | 1 | 1 | 1 |
| PDF Views & Downloads | 8 | 8 | 8 |
Gesundheitsökonomie und Ressourcenallokation am Lebensende
Health economics and resource allocation at the end of life
Universität Heidelberg & Deutsches Krebsforschungszentrum, Abteilung für Gesundheitsökonomie Heidelberg Deutschland
Search for other papers by Michael Schlander in
Current site
Google Scholar
PubMed
Abstract
Gesundheitsökonomische Evaluationen der medizinischen Versorgung am Lebensende, die qualitative Standards der Disziplin erfüllen, sind nach wie vor selten und weisen zwar auf Kosteneinsparungen hin, zeichnen aber hinsichtlich Kosteneffektivität kein einheitliches Bild. Im vorliegenden Beitrag wird argumentiert, dass die (quasi-)utilitaristische Logik, die konventionellen Kosten-Nutzen- und Kosteneffektivitäts-Analysen zugrunde liegt, zu Schlussfolgerungen führen kann, die weder mit vorherrschenden sozialen Normen und Präferenzen übereinstimmen noch aus ethischer Sicht überzeugen können.
Abstract
Health economic evaluations of medical care at the end of life, which fulfill established quality standards of the discipline, have remained scarce. While the literature points to potential cost savings, evidence on cost effectiveness is mixed. It will be argued that the underlying logic of conventional cost benefit and cost effectiveness analyses, which are inspired by utilitarian thought, may result in conclusions that are inconsistent with prevailing social norms and preferences, and may be less than convincing from an ethical perspective.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 8 | 8 | 8 |
| Full Text Views | 1 | 1 | 1 |
| PDF Views & Downloads | 8 | 8 | 8 |